BAM
RPID icon

Belpointe Asset Management’s Rapid Micro Biosystems RPID Stock Holding History

Belpointe Asset Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,100
Closed -$3.5K – 3833
2022
Q4 		$3.5K Buy
+3,100
New +$7.5K ﹤0.01% 3057

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Belpointe Asset Management's RPID Position: Q1 2023 in Review

Belpointe Asset Management sold out of Rapid Micro Biosystems (RPID) in Q1 2023, closing a stake of 3,100 shares — an estimated $3.5K sold.

Belpointe Asset Management first reported a position in RPID in Q4 2022 and held it in 1 quarter. The position peaked at $3.5K in Q4 2022. 31 funds tracked by Wall St. Rank hold RPID as of Q1 2023.

  • Belpointe Asset Management reported no remaining Rapid Micro Biosystems position as of Q1 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 3,100 Rapid Micro Biosystems shares in Q1 2023, an estimated $3.5K.
  • Belpointe Asset Management first reported a position in Rapid Micro Biosystems in Q4 2022 and held it in 1 quarter.
  • Belpointe Asset Management's Rapid Micro Biosystems position peaked at $3.5K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2023.

Based on Belpointe Asset Management's 13F filing for Q1 2023, filed 15 May 2023.